ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $151,000 | +67.8% | 25,000 | 0.0% | 0.03% | +62.5% |
| Q3 2019 | $90,000 | +34.3% | 25,000 | 0.0% | 0.02% | +33.3% |
| Q2 2019 | $67,000 | -9.5% | 25,000 | 0.0% | 0.01% | -7.7% |
| Q1 2019 | $74,000 | +85.0% | 25,000 | 0.0% | 0.01% | +62.5% |
| Q4 2018 | $40,000 | -56.5% | 25,000 | 0.0% | 0.01% | -50.0% |
| Q3 2018 | $92,000 | +8.2% | 25,000 | -16.7% | 0.02% | +6.7% |
| Q2 2018 | $85,000 | -23.4% | 30,000 | 0.0% | 0.02% | -25.0% |
| Q1 2018 | $111,000 | +29.1% | 30,000 | 0.0% | 0.02% | +33.3% |
| Q4 2017 | $86,000 | -36.3% | 30,000 | 0.0% | 0.02% | -37.5% |
| Q3 2017 | $135,000 | -26.6% | 30,000 | -25.0% | 0.02% | -31.4% |
| Q2 2017 | $184,000 | +9.5% | 40,000 | 0.0% | 0.04% | +9.4% |
| Q1 2017 | $168,000 | +1.8% | 40,000 | 0.0% | 0.03% | -3.0% |
| Q4 2016 | $165,000 | -49.1% | 40,000 | 0.0% | 0.03% | -50.7% |
| Q3 2016 | $324,000 | +3.8% | 40,000 | 0.0% | 0.07% | +1.5% |
| Q2 2016 | $312,000 | -4.9% | 40,000 | 0.0% | 0.07% | -5.7% |
| Q1 2016 | $328,000 | -24.1% | 40,000 | 0.0% | 0.07% | -21.3% |
| Q4 2015 | $432,000 | +56.5% | 40,000 | 0.0% | 0.09% | +48.3% |
| Q3 2015 | $276,000 | – | 40,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |